Jilin Aodong Pharmaceutical Group Co Ltd (000623) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.004x

Based on the latest financial reports, Jilin Aodong Pharmaceutical Group Co Ltd (000623) has a cash flow conversion efficiency ratio of 0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥112.12 Million ≈ $16.41 Million USD) by net assets (CN¥30.82 Billion ≈ $4.51 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Jilin Aodong Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Jilin Aodong Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Jilin Aodong Pharmaceutical Group Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Jilin Aodong Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jilin Aodong Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Thai Oil Public Company Limited
BK:TOP
0.135x
National Beverage Corp
NASDAQ:FIZZ
0.047x
WesBanco Inc
NASDAQ:WSBC
0.024x
Cohen & Steers Inc
NYSE:CNS
0.088x
WNS Holdings Ltd
NYSE:WNS
0.037x
GKG Precision Machine Co. Ltd. A
SHE:301338
-0.017x
Bains Mer Monaco
PA:BAIN
0.073x
Clicks
JSE:CLS
0.621x

Annual Cash Flow Conversion Efficiency for Jilin Aodong Pharmaceutical Group Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Jilin Aodong Pharmaceutical Group Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see Jilin Aodong Pharmaceutical Group Co Ltd (000623) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥29.28 Billion
≈ $4.28 Billion
CN¥59.48 Million
≈ $8.70 Million
0.002x -17.92%
2023-12-31 CN¥27.50 Billion
≈ $4.02 Billion
CN¥68.06 Million
≈ $9.96 Million
0.002x -84.62%
2022-12-31 CN¥26.34 Billion
≈ $3.85 Billion
CN¥423.86 Million
≈ $62.02 Million
0.016x +24.03%
2021-12-31 CN¥25.04 Billion
≈ $3.66 Billion
CN¥324.85 Million
≈ $47.54 Million
0.013x -21.81%
2020-12-31 CN¥23.53 Billion
≈ $3.44 Billion
CN¥390.41 Million
≈ $57.13 Million
0.017x -1.86%
2019-12-31 CN¥22.44 Billion
≈ $3.28 Billion
CN¥379.46 Million
≈ $55.53 Million
0.017x +3.32%
2018-12-31 CN¥21.24 Billion
≈ $3.11 Billion
CN¥347.64 Million
≈ $50.87 Million
0.016x +31.02%
2017-12-31 CN¥20.54 Billion
≈ $3.01 Billion
CN¥256.49 Million
≈ $37.53 Million
0.012x -29.39%
2016-12-31 CN¥18.87 Billion
≈ $2.76 Billion
CN¥333.81 Million
≈ $48.85 Million
0.018x -19.85%
2015-12-31 CN¥17.58 Billion
≈ $2.57 Billion
CN¥388.03 Million
≈ $56.78 Million
0.022x -3.28%
2014-12-31 CN¥12.66 Billion
≈ $1.85 Billion
CN¥288.83 Million
≈ $42.26 Million
0.023x +20.82%
2013-12-31 CN¥10.66 Billion
≈ $1.56 Billion
CN¥201.22 Million
≈ $29.44 Million
0.019x -32.39%
2012-12-31 CN¥9.75 Billion
≈ $1.43 Billion
CN¥272.40 Million
≈ $39.86 Million
0.028x +134.54%
2011-12-31 CN¥9.09 Billion
≈ $1.33 Billion
CN¥108.30 Million
≈ $15.85 Million
0.012x -50.47%
2010-12-31 CN¥7.25 Billion
≈ $1.06 Billion
CN¥174.22 Million
≈ $25.49 Million
0.024x -25.95%
2009-12-31 CN¥6.56 Billion
≈ $959.99 Million
CN¥213.03 Million
≈ $31.17 Million
0.032x -28.95%
2008-12-31 CN¥5.14 Billion
≈ $752.55 Million
CN¥235.03 Million
≈ $34.39 Million
0.046x -41.87%
2007-12-31 CN¥4.89 Billion
≈ $716.08 Million
CN¥384.69 Million
≈ $56.29 Million
0.079x -13.70%
2006-12-31 CN¥2.06 Billion
≈ $302.01 Million
CN¥187.99 Million
≈ $27.51 Million
0.091x +13.05%
2005-12-31 CN¥1.69 Billion
≈ $247.45 Million
CN¥136.26 Million
≈ $19.94 Million
0.081x -39.83%
2004-12-31 CN¥1.63 Billion
≈ $238.80 Million
CN¥218.53 Million
≈ $31.98 Million
0.134x +22.53%
2003-12-31 CN¥1.35 Billion
≈ $197.69 Million
CN¥147.65 Million
≈ $21.61 Million
0.109x +3025.54%
2002-12-31 CN¥1.22 Billion
≈ $179.23 Million
CN¥-4.58 Million
≈ $-669.59K
-0.004x -103.18%
2001-12-31 CN¥1.18 Billion
≈ $173.01 Million
CN¥138.76 Million
≈ $20.31 Million
0.117x +68.73%
2000-12-31 CN¥1.11 Billion
≈ $162.06 Million
CN¥77.04 Million
≈ $11.27 Million
0.070x -54.52%
1999-12-31 CN¥720.42 Million
≈ $105.42 Million
CN¥110.18 Million
≈ $16.12 Million
0.153x +414.76%
1998-12-31 CN¥635.85 Million
≈ $93.04 Million
CN¥-30.90 Million
≈ $-4.52 Million
-0.049x --

About Jilin Aodong Pharmaceutical Group Co Ltd

SHE:000623 China Drug Manufacturers - Specialty & Generic
Market Cap
$3.29 Billion
CN¥22.47 Billion CNY
Market Cap Rank
#4708 Global
#880 in China
Share Price
CN¥18.79
Change (1 day)
-0.63%
52-Week Range
CN¥16.17 - CN¥21.82
All Time High
CN¥24.39
About

Jilin Aodong Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China. The company provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in … Read more